Brooks Laboratories Limited has informed the Exchange about Update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per vial and 1gram per……
| Subscribe To Our Free Newsletter |
